Hong Kong has unveiled its inaugural five-year development plan, strategically positioning itself as a leading biomedicine hub in Asia. This comprehensive blueprint aligns with China's national initiatives while emphasizing collaborative efforts across the Greater Bay Area. The strategy focuses on advancing medical technology innovation, strengthening healthcare infrastructure, and fostering cross-border partnerships to enhance regional competitiveness in the global biotech sector.

Summary auto-generated by AI from the original publisher's content. Editorial standards.